Forty-two percent of respondents said that they substituted cannabis for prescription anxiolytics or antidepressants.
Day: July 9, 2026
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
The most significant reductions occurred in participants who consumed higher doses of CBD (up to 600 mg/day).
“In this systematic review, cannabinoid-based therapies showed lower neuropsychiatric symptom and agitation scores than placebo in patients with moderate-to-severe AD.”
Of the 937 products evaluated, only 31 percent contained percentages of CBD that were within ±10 percent of what was advertised on the products’ labels.